Easterly Investment Partners LLC Grows Position in Molina Healthcare, Inc $MOH

Easterly Investment Partners LLC raised its holdings in shares of Molina Healthcare, Inc (NYSE:MOH) by 227.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 38,082 shares of the company’s stock after purchasing an additional 26,464 shares during the quarter. Easterly Investment Partners LLC’s holdings in Molina Healthcare were worth $6,609,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in MOH. Baird Financial Group Inc. purchased a new stake in shares of Molina Healthcare in the first quarter worth about $210,000. NewEdge Advisors LLC lifted its holdings in shares of Molina Healthcare by 33.4% in the first quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock worth $364,000 after buying an additional 277 shares in the last quarter. Jones Financial Companies Lllp lifted its holdings in shares of Molina Healthcare by 713.3% in the first quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock worth $544,000 after buying an additional 1,448 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Molina Healthcare by 19.4% in the first quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company’s stock worth $82,172,000 after buying an additional 40,531 shares in the last quarter. Finally, Woodline Partners LP purchased a new stake in shares of Molina Healthcare in the first quarter worth about $1,541,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Molina Healthcare

In other news, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the transaction, the insider directly owned 67,175 shares in the company, valued at $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares of the company’s stock, valued at $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.44% of the company’s stock.

Molina Healthcare Stock Performance

Shares of MOH stock opened at $173.61 on Monday. The stock has a fifty day moving average of $163.77 and a 200 day moving average of $160.93. Molina Healthcare, Inc has a 52 week low of $121.06 and a 52 week high of $311.52. The firm has a market capitalization of $9.05 billion, a price-to-earnings ratio of 51.36 and a beta of 0.80. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $1.57 by $0.78. The business had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The company’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter last year, the firm posted $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, research analysts expect that Molina Healthcare, Inc will post 5.23 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Barclays lifted their target price on shares of Molina Healthcare from $161.00 to $199.00 and gave the company an “underweight” rating in a research report on Tuesday, May 26th. Bank of America upgraded shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price for the company in a research report on Wednesday, April 29th. Morgan Stanley lifted their target price on shares of Molina Healthcare from $128.00 to $146.00 and gave the company an “equal weight” rating in a research report on Friday, April 24th. Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Saturday, May 2nd. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Molina Healthcare in a research report on Tuesday, April 21st. Three analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Molina Healthcare currently has a consensus rating of “Hold” and an average target price of $178.53.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.